Charles River Laboratories Intl (CRL)

Charles River Labs (CRL) Stock Price & Analysis


CRL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$161.65 - $262.00
Previous Close$204.46
Average Volume (3M)532.54K
Market Cap
Enterprise Value$13.28B
Total Cash (Recent Filing)$157.17M
Total Debt (Recent Filing)$2.90B
Price to Earnings (P/E)22.1
Feb 14, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.23
Shares Outstanding51,296,804
10 Day Avg. Volume399,501
30 Day Avg. Volume532,537
Standard Deviation0.10
Financial Highlights & Ratios
Price to Book (P/B)-22.37
Price to Sales (P/S)2.64
Price to Cash Flow (P/CF)12.70
P/FCF Ratio15.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.44
Enterprise Value/Gross Profit9.08
Enterprise Value/Ebitda12.97
Price Target Upside2.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13



Ownership Overview

32.14% Mutual Funds
61.41% Other Institutional Investors
3.79% Public Companies and
Individual Investors


What was Charles River Laboratories Intl’s price range in the past 12 months?
Charles River Laboratories Intl lowest stock price was $161.65 and its highest was $262.00 in the past 12 months.
    What is Charles River Laboratories Intl’s market cap?
    Currently, no data Available
    When is Charles River Laboratories Intl’s upcoming earnings report date?
    Charles River Laboratories Intl’s upcoming earnings report date is Feb 14, 2024 which is in 66 days.
      How were Charles River Laboratories Intl’s earnings last quarter?
      Charles River Laboratories Intl released its earnings results on Nov 08, 2023. The company reported $2.72 earnings per share for the quarter, beating the consensus estimate of $2.357 by $0.363.
        Is Charles River Laboratories Intl overvalued?
        According to Wall Street analysts Charles River Laboratories Intl’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Charles River Laboratories Intl pay dividends?
          Charles River Laboratories Intl does not currently pay dividends.
          What is Charles River Laboratories Intl’s EPS estimate?
          Charles River Laboratories Intl’s EPS estimate is $2.41.
            How many shares outstanding does Charles River Laboratories Intl have?
            Charles River Laboratories Intl has 51,296,803 shares outstanding.
              What happened to Charles River Laboratories Intl’s price movement after its last earnings report?
              Charles River Laboratories Intl reported an EPS of $2.72 in its last earnings report, beating expectations of $2.357. Following the earnings report the stock price went down -3.742%.
                Which hedge fund is a major shareholder of Charles River Laboratories Intl?
                Among the largest hedge funds holding Charles River Laboratories Intl’s share is Ariel Investments LLC. It holds Charles River Laboratories Intl’s shares valued at 209M.

                  Company Description

                  Charles River Laboratories Intl

                  Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

                  Top 5 ETFs holding CRL

                  Market Value
                  Smart Score
                  Global X S&P 500 Covered Call ETF
                  iShares ESG Screened S&P 500 ETF
                  Global X S&P 500 Covered Call & Growth ETF
                  Global X S&P 500 Risk Managed Income ETF
                  Global X S&P 500 Tail Risk ETF
                  Up to five ETFs with an Outperform Smart Score that hold CRL. The ETFs are listed according to market value of CRL within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bio-Rad Laboratories
                  Popular Stocks
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis